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Abstract
Exercise training is a well-known coadjuvant in heart failure treatment; however, the molecular mechanisms underlying its
beneficial effects remain elusive. Despite the primary cause, heart failure is often preceded by two distinct phenomena:
mitochondria dysfunction and cytosolic protein quality control disruption. The objective of the study was to determine the
contribution of exercise training in regulating cardiac mitochondria metabolism and cytosolic protein quality control in a
post-myocardial infarction-induced heart failure (MI-HF) animal model. Our data demonstrated that isolated cardiac
mitochondria from MI-HF rats displayed decreased oxygen consumption, reduced maximum calcium uptake and elevated
H2O2 release. These changes were accompanied by exacerbated cardiac oxidative stress and proteasomal insufficiency.
Declined proteasomal activity contributes to cardiac protein quality control disruption in our MI-HF model. Using cultured
neonatal cardiomyocytes, we showed that either antimycin A or H2O2 resulted in inactivation of proteasomal peptidase
activity, accumulation of oxidized proteins and cell death, recapitulating our in vivo model. Of interest, eight weeks of
exercise training improved cardiac function, peak oxygen uptake and exercise tolerance in MI-HF rats. Moreover, exercise
training restored mitochondrial oxygen consumption, increased Ca2+-induced permeability transition and reduced H2O2
release in MI-HF rats. These changes were followed by reduced oxidative stress and better cardiac protein quality control.
Taken together, our findings uncover the potential contribution of mitochondrial dysfunction and cytosolic protein quality
control disruption to heart failure and highlight the positive effects of exercise training in re-establishing cardiac
mitochondrial physiology and protein quality control, reinforcing the importance of this intervention as a non-
pharmacological tool for heart failure therapy.
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Introduction
Heart failure is a common endpoint of most cardiovascular
diseases and a leading cause of morbidity and mortality worldwide.
There is a consensus that adjuvant therapies for cardiovascular
disease are able to increase patients’ quality of life and survival
rates [1]. Acting as a non-pharmacological therapy, exercise
training reduces a number of cardiovascular risk factors [2,3] and
has been recognized as an important and safe strategy for
preventing and treating heart failure [4,5,6]. However, the
underlying cellular mechanisms by which exercise training
improves heart failure patients’ clinical outcome are still under
investigation.
Mitochondrial dysfunction has been widely recognized as key
player in the progression of cardiovascular diseases [7]. Exacer-
bated generation of reactive oxygen species (ROS) due to impaired
mitochondrial bioenergetics is believed to underlie intra- and
extra-mitochondrial signal transduction during cardiac remodeling
and heart failure [8]. Evidences indicate that 4-hydroxy-2-nonenal
(4-HNE), a long-lived lipid peroxidation product that accumulates
during oxidative stress, irreversibly interacts with and inactivates
mitochondrial, cytosolic and membrane proteins [9,10,11].
However, the contribution of 4-HNE protein adduction to heart
failure pathophysiology remains elusive.
Over the last years, in vitro studies have demonstrated that
specific subunits of the 20S proteasome are targeted for
modification by 4-HNE, which results in reduced proteasomal
peptidase activities [9,10]. Recent findings showing that the
ubiquitin–proteasome system is negatively regulated by oxidative
stress during cardiac ischemia-reperfusion injury generated the
hypothesis that mitochondrial dysfunction-mediated redox imbal-
ance may negatively affect ubiquitin-proteasome activity in an
ATP-independent manner.
Over the past decades, the ubiquitin–proteasome system has
emerged as an important player on essential cellular processes
such as cellular proliferation, differentiation and apoptosis
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[12,13,14]. The ubiquitin–proteasome system is the primary
effector of the protein quality control process, protecting long-
lived cells, such as neurons and cardiomyocytes, through selective
removal of polypeptides that are terminally misfolded and toxic to
the cell [15]. Perturbations in the ubiquitin–proteasome system
have been shown to disturb protein turnover and thereby affect
cell function. Recent studies have highlighted the role of the
ubiquitin-proteasome system in stressed cardiac phenotypes
including cardiac remodelling and heart failure [16]. Accumula-
tion of ubiquitinated and damaged proteins is a common feature of
human failing hearts and indicates the relevance of the ubiquitin–
proteasome system in maintaining cardiac homeostasis [16,17].
However, it remains to be determined whether dysfunction of
specific protein quality control components, such as the ubiquitin–
proteasome system, contributes to the development of heart
failure, and which signaling events regulate them.
Despite the increased knowledge regarding the molecular basis
of mitochondrial ROS generation and redox balance in cardio-
vascular diseases, there is still uncertainty in the literature
regarding the contribution of the long-lived lipid peroxidation
product 4-HNE in protein modification and intracellular system
disruption in cardiovascular diseases. Some evidence indicates that
4-HNE modification of proteins is triggered by mitochondrial
dysfunction and provides an operational criterion for inactivation
of mitochondrial and cytosolic systems related to cell survival
[18,19]. Therefore, the objectives of the study were: 1) to test the
hypothesis that mitochondrial dysfunction disrupts cardiac protein
quality control through specific 4-HNE modification/inhibition of
proteasome and 2) to verify whether exercise training prevents
impairment of mitochondrial metabolism, 4-HNE adduct forma-
tion and protein quality control disruption in heart failure.
Materials and Methods
Study design
The present investigation was carried out in male Wistar rats
assigned into three experimental groups: sham (control, n = 9),
myocardial infarction-induced heart failure (MI-HF, n = 10) and
exercised-trained MI-HF (MI-HFtr, n = 8). Heart failure was
induced by myocardial infarction surgery. Four weeks later,
physiological parameters were determined and animals with heart
failure were randomly assigned into sedentary (MI-HF) and
exercise-trained (MI-HFtr) groups (Figure 1A). MI-HFtr rats
performed a moderate-intensity running training on a motor
treadmill over eight weeks (from 4th–6th month of age). At the end
of the protocol, physiological parameters were re-analysed. Forty-
eight hours later, all rats were killed by decapitation and cardiac
structure, bioenergetics and protein quality control measurements
were performed.
Animals and procedures
A cohort of male Wistar rats (250–300 g) was selected for the
study. Rats were maintained in a 12:12 h light-dark cycle and
temperature-controlled environment (22uC) with free access to
standard laboratory chow (Nuvital Nutrientes, Curitiba, PR Brazil)
and tap water. This study was conducted in accordance with the
ethical principles in animal research adopted by the Brazilian
College of Animal Experimentation (www.cobea.org.br). The
animal care and protocols in this study were reviewed and
approved by the Ethical Committee of Medical School of
University of Sa˜o Paulo (2008/40).
Myocardial infarction-induced heart failure model
Myocardial infarction was induced by ligation of the left
anterior descending coronary artery (LAD), as previously de-
scribed [20]. We have chosen this model since myocardial
infarction is the underlying etiology of heart failure in nearly
70% of patients [21]. Male Wistar rats were anesthetized with
ketamine (50 mg.kg21 IP) and xylazine (10 mg.kg21 IP), endo-
tracheally intubated, and mechanically ventilated with room air
(respiratory rate of 60–70 breaths/min and tidal volume of
2.5 mL). Left thoracotomy between the fourth and fifth ribs was
performed and the LAD was ligated. After the surgery, animals
were monitored daily. Heart failure was observed four weeks after
coronary artery ligation and was defined when animal presented
pathological cardiac remodeling accompanied by left ventricle
dysfunction, cardiac dilation and exercise intolerance (Tables 1
and 2), according to the Guidelines of American Heart Association
[22]. Left thoracotomy with equal procedure duration to that of
heart failure group, but without LAD ligation, was undertaken in
the sham group (control).
Graded treadmill exercise test and oxygen uptake
measurement
After being adapted to treadmill exercises and the test
environment for over one week (10 minutes each session), rats
were placed on the exercise streak inside a metabolic chamber
equipped with plastic tubes that allowed air into the chamber and
out to a high-resolution oxygen analyzer (FC-10, Sable Systems
International, Las Vegas, USA). Ambient air was pumped into the
chamber (3500 mL.min21), continuously extracted at the same
rate and directed to the oxygen analyzer. Oxygen fraction in
effluent air was registered every second. The analyzer was
calibrated with known gas mixtures every day of tests. Each rat
had a twenty-minute rest period and a ten-minute warm-up at
3 m.min21 before the test protocol. Treadmill speed was increased
by 3 m.min21 every 3 minutes until the animal was unable to run
[23]. We considered the VO2 reached at the highest workload
during the treadmill test as peak VO2. It is worth mentioning that
peak VO2 has been described to the best predictor of mortality in
humans with cardiovascular diseases [24]. VO2 (mL
O2
.kg21.min21) was calculated using the measured flow through
the metabolic chamber (3500 mL.min21), expired fraction of
effluent oxygen (E), fraction of oxygen in room air (A) and rat body
mass (M [kg]), as described by the formula:
VO2= [35006(A2E)]/M. Peak VO2 was measured both before
(week 16) and after experimental protocol (week 24) (Figure 1).
Running training protocol
Heart failure rats performed moderated-intensity running
training on a motor treadmill, 5 days/wk, 60 min/day. Running
speed and duration of exercise were progressively increased to
elicit 60% of maximal speed at the second week of training,
corresponding to the maximal lactate steady state workload [25].
At the fourth week of training, run capacity was evaluated in order
to readjust exercise training intensity. Treadmill running skills
were maintained in sedentary HF and sham rats by treadmill
running for 5 min, twice a week. This procedure was performed in
order to avoid any interference of treadmill stress on the variables
studied. This latter activity did not seem to alter maximal exercise
capacity (Table 1).
Cardiovascular measurements
Heart rate and blood pressure were determined noninvasively
using a computerized tail-cuff system (BP 2000 Visitech Systems)
Exercise Training in Heart Failure
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described elsewhere [26]. Rats were acclimatized to the apparatus
during daily sessions over 4 days, one week before starting the
experimental period.
Non-invasive cardiac function evaluation was performed by M-
mode echocardiography in anesthetized (isoflurane 3%) sham and
HF rats, four and twelve weeks after surgery. Briefly, rats were
Figure 1. Exercise training improves cardiac function and exercise tolerance in myocardial infarction-induced heart failure.
Schematic panel (A). Fractional shortening (B), distance run (C), heart rate (D) and blood pressure (E) in control (sham, white bars), MI-HF (gray bars)
and MI-HF exercise trained (MI-HFtr, gray bars) rats before and after 8 wks of either sedentary or exercise training protocol. Error bars indicate SEM.
Interaction between main effects: fractional shortening [F (2, 15) = 5.28, p = 0.0183]; distance run [F (2, 31) = 48.97, p,0.0001]; heart rate [F (2,
13) = 4.06, p = 0.0425] and blood pressure [F (2, 13) = 1.05, p = 0.3764]. 1, p,0.05 vs. before experimental protocol. *, p,0.05 vs. control (sham) rats. {,
p,0.05 vs. MI-HFtr rats.
doi:10.1371/journal.pone.0052764.g001
Table 1. Physiological parameters.
Before experimental protocol (16 wk) After experimental protocol (24 wk)J
Parameter Control (9) MI-HF (7) MI-HFtr (7) Control (9) MI-HF (7) MI-HFtr (7)
Peak VO2, mL O2?kg
21?min21 65.661.8 67.562.4 68.463.2 58.762.5 47.862.4 66.363.1
BW, g 418612 390611 391611 432622 429614 415612
CS activity, mmol?mg21?min21 - - - 44766718 32006677*{ 638661007*
HW/BW, mg?g21 - - - 2.060.1 2.460.1* 2.460.1*
MI area, % - - - - 3163 3564
Cardiomyocyte width, mm - - - 14.3360.17 14.9060.17* 14.4260.22
Cardiac collagen content, % - - - 5.4560.33 6.7760.44*{ 5.6660.32
Peak VO2 (in mL O2?kg
21?min21), body weight (BW in grams), soleus muscle citrate synthase activity (CS in mmol?mg21?min21), heart weight/body weight ratio (HW/
BW), myocardial infarction (MI) area, cardiomyocyte width (mm) and cardiac collagen content (%) data in control (sham), MI-HF and MI-HF exercise trained (MI-HFtr) rats
(Mean 6 SEM).
JMain time effect: peak VO2 [F (1, 18) = 9.75, p = 0.0058] pre-training values.post-training values and BW [F (1, 16) = 10.73, p = 0.0047]. CS activity [F (2, 21) = 29.80,
p,0.0001] *MI-HF,control (p = 0.0047) and {MI-HFtr (p,0.0001), *MI-HFtr.control (p = 0.0002); HW/BW [F (2, 16) = 8.55, p = 0.0029] *control,MI-HF (p = 0.0044) and
MI-HFtr (p = 0.0036); cardiomyocyte width [F (2, 14) = 11.42, p,0.0001] *MI-HF.control (p,0.0001) and cardiac collagen content [F (2, 23) = 3.76, p = 0.0245] *MI-
HF.control (p = 0.0189) and {MI-HFtr (p = 0.0311).
doi:10.1371/journal.pone.0052764.t001
Exercise Training in Heart Failure
PLOS ONE | www.plosone.org 3 December 2012 | Volume 7 | Issue 12 | e52764
positioned in the supine position with front paws wide open and
ultrasound transmission gel was applied to the precordium.
Transthoracic echocardiography was performed using an Acuson
Sequoia model 512 echocardiographer equipped with a 14-MHz
linear transducer. Left ventricle systolic function was estimated by
fractional shortening (FS) as follows: FS(%) = [(LVEDD2L-
VESD)/LVEDD]6100, where LVEDD is the left ventricular
end-diastolic diameter, and LVESD is the left ventricular end-
systolic diameter.
Cardiac structural analysis
Forty-eight hours after the end of protocol, all rats were killed by
decapitation and their tissues were harvested. Cardiac chambers
were then fixed by immersion in 4% buffered formalin and
embedded in paraffin for routine histological processing. Sections
(4 mm) were stained with Hematoxylin-eosin, Picrosirius red or
Masson’s trichrome for the quantification of the cardiomyocyte
width, cardiac collagen content and myocardial infarct area,
respectively. These measurements were performed in the left
ventricle free wall with a computer-assisted morphometric system
(Leica Quantimet 500, Cambridge, UK, England), as described
previously [27]. The myocardial infarcted area was expressed as a
percentage of total surface area of the left ventricle [28].
Citrate synthase activity
Soleus muscles were homogenized in phosphate buffer (50 mM
sodium phosphate, 1 mM EDTA and protease inhibitor cocktail
(Sigma-Aldrich), pH 7.4) and centrifuged for 15 minutes at
12000 g and 4uC, pellet was discarded and supernatant was used
for the assay. Assay mixture contained 100 mM Tris, 1 mM
EDTA, 0.2 mM DTNB, 0.1 mM acetil-CoA, 1% (v:v) Triton X-
100, sample (130 mg of soluble proteins per mL of total assay) and
0.5 mM oxaloacetate (added latest), as originally described [29].
Sample absorbance was monitored at 412 nm in 96-well plate
during 10 minutes at 25uC and maximal citrate synthase activity
was measured within the linear range of the assay.
Mitochondrial isolation
Heart mitochondria were isolated as described elsewhere [30].
Briefly, cardiac samples from a remote area were minced and
homogenized in isolation buffer (300 mM sucrose, 10 mM Hepes,
2 mM EGTA, pH 7.2, 4uC) containing 0.1 mg.mL21 of type I
protease (bovine pancreas) to release mitochondria from within
muscle fibers and later washed in the same buffer in the presence
of 1 mg.mL21 bovine serum albumin. The suspension was
homogenized in a 40 mL tissue grinder and centrifuged at 950 g
for 5 min. The resulting supernatant was centrifuged at 9500 g for
10 min. The mitochondrial pellet was washed, resuspended in
isolation buffer and submitted to a new centrifugation (9500 g for
10 min). The mitochondrial pellet was washed and the final pellet
was resuspended in a minimal volume of isolation buffer.
Mitochondrial H2O2 release
Mitochondrial H2O2 release was measured as described
elsewhere [31]. Briefly, mitochondrial H2O2 release was measured
in a 0.125 mg protein.mL21 mitochondrial suspensions in buffer
containing 125 mM sucrose, 65 mM KCl, 10 mM Hepes, 2 mM
inorganic phosphate, 2 mM MgCl2, 100 mM EGTA and 0.01%
bovine serum albumin, pH 7.2, at 30uC, with continuous stirring.
Amplex Red (25 mM) oxidation was followed in the presence of
0.5 U.mL21 horseradish peroxidase and using succinate, malate
and glutamate (2 mM of each) as substrates. Amplex Red is
oxidized in the presence of extramitochondrial horseradish
peroxidase bound to H2O2, generating resorufin, which can be
detected using a fluorescence spectrophotometer. Excitation/
emission wavelengths were 563/587 nm. Calibration was con-
ducted by adding H2O2 at known concentrations (A240 = 43.6
M21.cm21) to the experimental buffer.
Mitochondrial O2 consumption
Mitochondrial O2 consumption was monitored in a 0.25 mg
protein.mL21 mitochondrial suspension under the same condi-
tions as H2O2 release measurements using a computer-interfaced
Clark-type electrode (OROBOROS Oxygraph-2k) operating with
continuous stirring at 37uC [31]. Succinate, malate and glutamate
(2 mM of each) were used as substrates and ADP (1 mM) was
added to induce State 3 respiratory rate. A subsequent addition of
oligomycin (1 mg.mL21) was used to determine State 4 rate.
Respiratory control ratio (RCR) was calculated by dividing State 3
by State 4 oxygen consumption rates, which demonstrates the
tightness of the coupling between mitochondrial respiration and
phosphorylation.
Table 2. Echocardiographic measurements.
Before experimental protocol (16 wk) After experimental protocol (24 wk)J
Parameter Control (9) MI-HF (7) MI-HFtr (7) Control (9) MI-HF (7) MI-HFtr (7)
EF, % 83.261.22 47.263.89* 48.064.43* 79.263.45 47.065.04*{ 64.366.16*1
IVSd, mm 1.460.02 1.260.08 1.260.06 1.560.05 1.260.05 1.460.11
IVSs, mm 2.560.10 1.360.10 1.360.09 2.660.13 1.560.13 2.060.29
LVEdD, mm 7.060.14 9.160.27 8.760.21 7.960.29 9.160.13 8.760.4
LVEsD, mm 3.760.14 7.260.24 6.860.23 4.560.37 7.260.51 6.060.63
LVPWd, mm 1.460.03 1.660.09 1.560.13 1.660.08 1.360.061 1.560.12
LVPWs, mm 2.660.14 2.660.17 2.760.20 2.760.18 2.260.13 2.760.24
Left ventricular ejection fraction (EF), interventricular septum in diastole (IVSd), interventricular septum in systole (IVSs), left ventricular end-diastolic diameter (LVEdD),
left ventricular end-systolic diameter (LVEsD), left ventricular posterior wall in diastole (LVPWd) and left ventricular posterior wall in systole (LVPWs) were obtained
before and after 8 wks of the experimental protocol in control (sham), MI-HF and MI-HF exercise trained (MI-HFtr) rats (Mean 6 SEM). Interaction between main effects:
EF [F (2, 15) = 6.84, p = 0.0077] *control.MI-HF (p,0.0001) and MI-HFtr (p,0.0001) before and after experimental protocol, {MI-HFtr.MIHF after experimental protocol
(p = 0.0136) and 1MI-HFtr before,after experimental protocol (p = 0.0167); and LVPWd [F (2, 15) = 4.52, p = 0.0289] 1MI-HF before.after experimental protocol
(p = 0.0401).
JMain time effect: IVSs [F (1, 15) = 5.98, p = 0.0272] pre-training values,post-training values.
doi:10.1371/journal.pone.0052764.t002
Exercise Training in Heart Failure
PLOS ONE | www.plosone.org 4 December 2012 | Volume 7 | Issue 12 | e52764
Maximal mitochondrial calcium uptake
Extramitochondrial Ca2+ concentrations were measured in a
0.125 mg protein.mL21 mitochondrial suspensions using the
fluorescent probe Calcium Green (100 nM) as described [32].
The reactions were carried out under the same conditions as H2O2
release measurements with continuous stirring at 37uC. For each
experiment, consecutive additions of 50 mM CaCl2 were made
until the mitochondria failed to reduce extramitochondrial Ca2+.
We therefore plotted a calibration curve that correlates fluores-
cence and Ca2+ concentration. Succinate, malate and glutamate
(2 mM of each) were used as substrates and 100 mM EGTA was
used to establish the baseline. Excitation/emission wavelengths
were 506/532 nm.
In vitro 4-hydroxy-2-nonenal modification of proteasome
Either 50 mg of heart lysate from control (sham) animals or 2 mg
of purified 20S proteasome (PW8720, Enzo Lif Sci, PA) were
incubated with different concentrations of 4-HNE (10 or 100 mM)
in assay buffer containing 25 mM Tris-HCl, 1 mM CaCl2,
20 mM MgCl2, pH 7.5 at 37uC for 60 minutes. Dithiothreitol
(DTT, 1 mM) was added to the reaction either 30 minutes prior or
after 4-HNE incubation to assess the reversibility of 4-HNE
modification of proteasome. Measurement of proteasome activity
was carried out after finishing the in vitro assay.
Proteasome activity
ATP-dependent chymotrypsin-like activity of the proteasome
was assayed in the total lysate from heart, isolated cardiomyocyte
or purified proteasome using the fluorogenic peptide Suc-Leu-
Leu-Val-Tyr-7-amido-4-methylcoumarin (LLVY-AMC, 25 mM).
The assay was performed in a microtiter plate (FlexStation II 384,
Molecular Device Inc, CA), in assay buffer containing 25 mM
Tris-HCl, 5.0 mM MgCl2, 25 mM ATP, pH 7.5. Kinetic analyses
were carried out using 50 mg of protein for 30 min at 37uC in the
presence and absence of 1 mM epoxomicin (a selective proteasome
inhibitor), with the difference attributed to ATP-dependent
proteasomal activity. Excitation/emission wavelengths were 350/
440 nm. Proteasome activity was linear for 30 min under the
conditions of the assays.
Cell culture
Cardiac myocytes were isolated from 1-day-old Sprague-
Dawley rat litters, as described [33].
Cell death
Cell death was measured using the cytotoxicity detection kit
(Roche), which measures LDH released in the medium. Percent-
age cytotoxicity was calculated according to the manufacturer’s
instructions.
Immunoprecipitation
Total lysate of rat heart (500 mg protein) was incubated with the
indicated antibodies for 3 h at 4uC, followed by incubation with
protein A/G agarose beads (Santa Cruz Biotechnology) for 1 h at
4uC. The immunoprecipitates were separated on SDS–PAGE and
transferred onto nitrocellulose membranes. The membranes were
then probed with the indicated antibodies.
Western blot
20S proteasome (a5/a7, b1, b5, b7 subunits), polyubiquitinated
proteins, soluble oligomers, HSP25, ab-crystallin and 4-HNE
expression levels were evaluated by western blotting in total
extracts from the ventricular remote area. Briefly, samples were
subjected to SDS-PAGE in polyacrylamide gels (6–15%) depend-
ing upon protein molecular weight. Cardiac soluble oligomers
levels were evaluated in non-denaturating gel electrophoresis
according to Glabe et al. (2004) [34]. After electrophoresis,
proteins were electrotransferred to nitrocellulose membranes
(BioRad Biosciences; Piscataway, NJ, USA). Equal gel loading
and transfer efficiency were monitored using 0.5% Ponceau S
staining of blot membrane. Blotted membrane was then blocked
(5% nonfat dry milk, 10 mM Tris-HCl (pH=7.6), 150 mM NaCl,
and 0.1% Tween 20) for 2 h at room temperature and then
incubated overnight at 4uC with specific antibodies against 20S
proteasome (a5/a7, b1, b5, b7 subunits) and polyubiquitinated
proteins (Biomol Int., PA, USA), HSP25 and ab-crystallin
(Stressgen, MI, USA), 4-HNE (Calbiochem, HE, Germany),
GAPDH (Advanced Immunochemical Inc. CA, USA) and soluble
oligomers A11 (Invitrogen, CA, USA). Binding of the primary
antibody was detected with the use of peroxidase-conjugated
secondary antibodies (rabbit or mouse, depending on the protein,
for 2 h at room temperature) and developed using enhanced
chemiluminescence (Amersham Biosciences, NJ, USA) detected by
autoradiography. Quantification analysis of blots was performed
with the use of Scion Image software (Scion based on NIH image).
Samples were normalized to relative changes in GAPDH and
expressed as percent of control.
Cellular oxidized proteins
Protein oxidation was determined as previously described [35].
The carbonyl groups in the protein side chains were derivatized to
2,4-dinitrophenylhydrazone (DNPhydrazone) by reaction with
2,4-dinitrophenylhydrazine (DNPH). The DNP-derivatized pro-
tein samples were separated by polyacrylamide gel electrophoresis
followed by Western blotting.
Statistical analysis
Data are presented as means 6 standard error of the mean
(SEM). Data normality was assessed through Shapiro-Wilk’s test
and those no presenting normal distribution were log transformed
(i.e. distance run and peak VO2 before experimental protocol, and
interventricular septum in diastole before and after experimental
protocol). One-way analysis of variance (ANOVA) was used to
analyze data presented in Figures 2, 3, 4, 5A–C and 6. Two-way
ANOVA for repeated measures was used to analyze data depicted
in Figure 1 and Tables 1 and 2. Whenever significant F-values
were obtained, Tukey’s adjustment was used for multiple
comparison purposes (p-values displayed on Tables 1 and 2
legends). Statistical significance was considered achieved when the
value of P was ,0.05. Linear regression was used to assess the
association between variables in Figure 5D.
Results
Exercise training improves cardiac function and oxygen
uptake in heart failure animals
At four weeks after myocardial infarction surgery (Figure 1A),
heart failure rats displayed reduced cardiac function and exercise
intolerance (Figures 1B–C). These changes were accompanied by
a pathological cardiac remodeling, depicted by increased heart
weight/body weight ratio (HW/BW), left ventricular dilation,
cardiomyocyte hypertrophy and elevated cardiac fibrosis com-
pared to control animals (Tables 1 and 2). No changes in heart
rate and blood pressure were observed (Figures 1D and E).
Eight weeks of aerobic exercise training (Figure 1A) significantly
increased cardiac function, depicted by elevated ventricular
fractional shortening and ejection fraction in heart failure animals
Exercise Training in Heart Failure
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(Figure 1B and Table 2). These findings were accompanied by a
cardiac anti-remodeling effect, characterized by reduction of both
cardiac collagen deposition and left ventricular dilation (Tables 1
and 2). Exercise training had no effect on HW/BW ratio and
myocardial infarction area (Table 1). Cardiomyocyte width was
normalized in trained heart failure animals towards control group
(Table 1). Based on the data described above, we demonstrate a
switch from pathological to physiological cardiac remodeling in
trained heart failure animals, since exercise training improved
cardiac function along with a prominent morphological change.
These findings corroborate our previous work showing that
aerobic exercise training promotes a cardiac anti-remodelling
effect in a sympathetic hyperactivity-induced heart failure animal
model [36]. Finally, the effectiveness of exercise training was
demonstrated by increased exercise capacity, peak VO2, citrate
synthase activity and resting bradycardia in the trained heart
failure animals (Figure 1C–D and Table 1).
Failing hearts display reduced mitochondrial function
and exacerbated ROS release
Impaired mitochondrial metabolism associated with increased
ROS release has been shown to contribute to a number of
cardiovascular diseases [7,37]. In order to assess mitochondrial
function in failing hearts, we measured oxygen consumption and
maximum calcium uptake in isolated mitochondria from 24 week-
old myocardial infarction-induced heart failure rats and age-
matched controls (Figure 2A–D). Our results indicate that heart
failure rats displayed reduced state 3 respiratory rate along with a
significant decrease in the efficiency of mitochondrial oxidative
phosphorylation compared to control (sham) animals, as measured
by respiratory control ratio (State 3/State 4) (Figure 2A–C). Of
interest, reduced mitochondrial efficiency was paralleled by the
inability of heart failure animals to perform prolonged physical
activity (Table 1). Isolated mitochondria from failing hearts also
displayed impaired maximum calcium uptake (Figure 2D). Strik-
ingly, a moderate exercise training protocol (over 8 weeks)
increased both state 3 and state 4 respiratory rates as well as re-
established the efficiency of mitochondrial oxidative phosphoryla-
tion (Figures 2A–C). Moreover, exercise training improved
maximum calcium uptake and exercise tolerance in heart failure
animals (Figures 2D and Table 1).
Considering that ROS release has been strongly associated with
changes in oxygen consumption and heart failure [7], we decided
to measured H2O2 release in isolated mitochondria from 24 week-
old failing hearts. Our results demonstrated that H2O2 release was
significantly increased in mitochondria from heart failure animals
compared to age-matched control group (Figure 2E). Interestingly,
exercise training decreased mitochondrial H2O2 release to control
group values.
Figure 2. Exercise training improves oxygen consumption and reduces H2O2 release in cardiac isolated mitochondria from
myocardial infarction-induced heart failure animal. Mitochondrial state 3 (A) and state 4 (B) respiratory rates; respiratory control ratio (C);
maximum calcium uptake (D) and H2O2 release (E) in heart samples from 24 week-old control (sham, white bars), MI-HF (gray bars) and MI-HF exercise
trained (MI-HFtr, gray bars) rats. All measurements were performed in the ventricular remote area. Error bars indicate SEM. Mitochondrial state 3 [F (2,
41) = 8.62, p = 0.0007] and state 4 [F (2, 41) = 8.86, p = 0.0006] respiratory rates; respiratory control ratio [F (2, 45) = 3.26, p = 0.0475]; maximum calcium
uptake [F (2, 14) = 5.72, p = 0.0152] and H2O2 release [F (2, 37) = 5.28, p = 0.0095]. *, p,0.05 vs. control (sham) rats. {, p,0.05 vs. MI-HFtr rats.
doi:10.1371/journal.pone.0052764.g002
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4-HNE modification inhibits proteasomal peptidase
activity in heart failure
Elevated ROS release has been generally implicated in cellular
damage during pathological processes. The introduction of
carbonyl functional groups into proteins by 4-HNE, a major
product of ROS-mediated lipid oxidation, has been reported to
induce protein inactivation during ischemia-reperfusion injury
[38]. Here, we found that non-infarcted cardiac zone from 24
week-old heart failure rats displayed exacerbated accumulation of
4-HNE-protein adducts compared to control animals (Figure 3A).
Moreover, immunoprecipitation experiments showed that 4-HNE
modifications of the 20S proteasome were elevated in failing hearts
compared to controls (Figure 3B). Interestingly, exercise training
was able to reduce the formation of adducts between 4-HNE and
20S proteasome in heart failure animals (Figure 3A–B).
Because oxidative modifications of the proteasome have been
reported to reduce its proteolytic activity during ischemia-
reperfusion injury [9], we decided to evaluate the efficacy of the
proteasome chymotrypsin-like site (the main proteolytic site
involved in peptide degradation) to cleave the artificial substrate
LLVY-AMC in vitro. These experiments were performed in the
non-infarcted cardiac zone from 24 week-old heart failure rats and
their age-matched controls. As shown in Figure 3C, proteasomal
activity was strikingly reduced in failing hearts compared to
controls, with no changes in protein expression of 20S proteasome
subunits (a5/a7, b1/b5/b7) (Figure 3D and F). Reduction of
proteasomal activity was accompanied by accumulation of
polyubiquitinated proteins in failing hearts (Figures 3E and F).
Interestingly, exercise training re-established proteasomal activity
and decreased polyubiquitinated protein levels in failing hearts.
Therefore, our results suggest that exercise training prevents 20S
proteasome dysfunction in heart failure, likely due to formation of
4-HNE adducts.
In vitro 4-HNE modification inhibits proteasomal activity
in an irreversible manner
To directly test the effect of 4-HNE modification on proteasome
function, purified 20S proteasome was incubated with 4-HNE for
60 min at 37uC (Figure 4A). In vitro incubation of purified 20S
proteasome with different concentrations of 4-HNE (10 and
100 mM) resulted in a significant reduction of proteasomal activity
(Figure 4B). In order to test whether proteasome inhibition was
Figure 3. Exercise training decreases 4-HNE modification of proteasome and re-establishes cardiac ubiquitin-proteasome system
function in myocardial infarction-induced heart failure. (A) 4-HNE protein adducts in heart samples from 24 week-old control (sham), MI-HF
and MI-HF exercise trained (MI-HFtr) rats. Protein expression was normalized by GAPDH. Inset: Representative blot of 4-HNE protein adducts. Black
arrows indicate changes in the adduct formation in MI-HF and MI-HFtr samples, red arrows indicate changes in the adduct formation of proteins at
the molecular weight of proteasomal subunits. (B) 20S proteasome subunits (a5/a7, b1, b5, b7) were precipitated from left ventricle tissue from 24-
week-old control, MI-HF and MI-HFtr rats (B, n = 3 per group), and then probed with 4-HNE-modified proteins antibody. Equal sample loading was
verified using a5/a7, b1, b5 and b7 proteasome subunits antibody. (C) Chymotrypsin-like activity of 26S proteasome, (D) 20S proteasome a5/a7, b1,
b5, b7 protein levels and (E) polyubiquitinated proteins levels in heart samples from 24 week-old control, MI-HF and MI-HFtr rats. Protein expression
was normalized by GAPDH. (F) Representative blots of polyubiquitinated proteins, 20S proteasome and GAPDH. All measurements were performed in
the ventricular remote area. Error bars indicate SEM. 4-HNE protein adducts [F (2, 15) = 42.58, p,0.0001]; chymotrypsin-like activity of 26S proteasome
[F (2, 25) = 12.90, p = 0.0001]; 20S proteasome a5/a7, b1, b5, b7 [F (2, 18) = 0.81, p = 0.4595] and polyubiquitinated proteins levels [F (2, 18) = 4.19,
p = 0.0318]. *, p,0.05 vs. control (sham) rats. {, p,0.05 vs. MI-HFtr rats.
doi:10.1371/journal.pone.0052764.g003
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mediated by oxidative modifications, purified 20S proteasome was
pre-treated with DTT (1 mM). Indeed, reduction of free sulphydryl
groups prior to incubation with either 10 mM or 100 mM of 4-
HNE was effective to protect the proteasome against oxidative
modification-mediated inhibition. Another explanation for the
benefits of DTT pre-treatment might be related to a direct
neutralization of 4-HNE oxidative capacity. Interestingly, DTT
post-treatment of purified 20S proteasome did not rescue the
proteasomal inactivation mediated by 4-HNE modifications.
These results demonstrate that 4-HNE modification induces
inactivation of proteolytic 20S proteasome activity in vitro in an
irreversible manner.
Oxidative stress contributes to proteasomal inactivation,
accumulation of damaged proteins and cell death in
cultured neonatal cardiomyocytes
In order to validate our in vivo and in vitro findings showing that
mitochondrial dysfunction-mediated oxidative modification inac-
tivates proteasome and results in accumulation of damaged
proteins, we challenged cultured neonatal cardiomyocytes isolated
from rats with either antimycin A (a mitochondrial complex III
inhibitor) or H2O2. Antimycin A (100 mM) resulted in a significant
reduction of in vitro proteolytic proteasomal activity in an ATP-
independent manner, since ATP was added during in vitro
measurements (Figure 5A). Antimycin A-mediated proteasomal
inhibition was accompanied by accumulation of oxidized proteins
and elevated cardiomyocytes death (Figures 5B–C). These findings
demonstrate that mitochondrial dysfunction-mediated ROS
release inactivates proteasome and impairs removal of damaged
proteins. Indeed, treatment of cardiomyocytes with either H2O2
(100 mM) or Epoxomicin (1 mM, a selective proteasome inhibitor)
drastically reduced proteasomal activity along with accumulation
of oxidized proteins and cell death (Figures 5A–C). Finally, we
found a tight correlation between proteasomal inactivation,
accumulation of oxidized proteins and cell death in cultured
neonatal cardiomyocytes treated with antimycin A, H2O2 or
Epoxomicin (Figure 5D).
Proteasomal inhibition disrupts cardiac protein quality
control in heart failure rats
The ubiquitin proteasome system is the primary effector of the
protein quality control process in cardiomyocytes [39]. Consider-
ing our in vivo and cell cultured findings demonstrating that
mitochondrial dysfunction mediates inactivation of proteasome
and accumulation of damaged proteins, we evaluated the cardiac
protein quality control profile in 24 week-old myocardial
infarction-induced heart failure rats.
Heart failure animals displayed significant accumulation of
oxidized proteins compared to age-matched controls (Figure 6A
and E). In order to test whether decreased proteasomal activity
would contribute to misfolded proteins accumulation, we evalu-
ated cardiac soluble pre-amyloid oligomers levels in heart failure
rats. In fact, myocardial infarction-induced heart failure rats
presented a significant increase of misfolded proteins levels
compared with control hearts (Figure 6B and E). Moreover, heart
failure rats presented a significant increase in HSP25 protein levels
compared to controls (Figure 6C and E). Our findings showing
inhibition of the proteasome along with accumulation of damaged
proteins and increased expression of small chaperones demon-
strate a clear disruption of protein quality control in failing hearts.
Interestingly, exercise training reduced cardiac oxidized and
misfolded proteins levels in heart failure rats compared with age-
matched non-trained heart failure animals (Figure 6A–B and E).
This profile was accompanied by a reduction of small chaperone
levels in trained animals (Figure 6C and E), suggesting that
improved proteasomal activity mediated by aerobic exercise
training contributes, at least in part, to better cardiac protein
quality control in heart failure.
Discussion
Over the past decades, significant progression has been made in
understanding the cellular processes involved in heart failure,
which has positively contributed to drug development in this field.
However, in spite of new therapies able to improve patient’s
quality of life and survival [1], heart failure remains the main cause
of death worldwide. Thus, there is a compelling need for new
pharmacological and non-pharmacological therapies that could
improve clinical outcomes. To fulfil this issue, a number of studies
have focused on identifying intracellular distal strategic nodes
where signals converge and/or serve as multi-effector brakes to
suppress or reverse heart failure, which would become attractive
targets for heart failure therapy.
Due to its pivotal role in bioenergetics, calcium homeostasis,
redox regulation and cell death, mitochondria have been
considered an intracellular organelle capable of orchestrating
biochemical processes across the cell [40]. Indeed, much of the
current research focuses on understanding the crosstalk between
mitochondrial and the rest of the cell. In the present study, we
found that mitochondrial dysfunction-associated 4-HNE accumu-
lation, a highly reactive a,b-unsaturated aldehyde and a major
secondary product of lipid peroxidation, contributes to protein
quality control disruption by directly targeting the proteasome in
Figure 4. 4-HNE irreversibly inactivates 20S proteasome in
vitro. (A) Schematic panel of in vitro incubations. (B) Purified 20S
proteasome (1 ug) was incubated for 30 min at 37uC with 4-HNE (10 or
100 mM) and proteasomal activity was measured at the end of
incubation. DTT (1m) was added to the reaction either previous or after
4-HNE incubations. Of interest, prior, but no later, incubation with DTT
protected 4-hydroxi-2-nonenal inhibition of proteasomal activity. Error
bars indicate SEM. Proteasomal activity [F (7, 32) = 21.37, p,0.0001]. *,
p,0.05 vs. control, 4-HNE (10 mM)+DTT (before). #, p,0.05 vs. 4-HNE
(10 mM).
doi:10.1371/journal.pone.0052764.g004
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failing hearts. Moreover, we demonstrated that in vitro 4-HNE-
modification/inactivation of proteasome occurs in an irreversible
manner, while reduction of free sulphydryl groups prior to 4-HNE
incubation abolished the inhibition of proteasomal chymotrypsin-
like activity. Our study has shown for the first time that
modification/inactivation of the cardiac proteasome by the lipid
peroxidation product 4-HNE occurs in heart failure. Others have
observed the same phenomenon during acute coronary occlusion/
reperfusion, cerebral ischemia and aging [9,18].
The proteasome has been implicated in the removal of
polyubiquitinated and oxidatively modified proteins
[41,42,43,44]. Therefore, impairment of proteasomal proteolytic
activity by 4-HNE may negatively affect cellular protein quality
control and further contributes to cell death. In agreement with
these findings, we observed a striking inactivation of proteasomal
chymotrypsin-like activity paralleled by accumulation of oxida-
tively modified, misfolded and polyubiquitinated proteins in failing
hearts. These responses were accompanied by increased expres-
sion of small chaperones. Over-expression of small chaperones
such as HSP25 and ab crystallin is related to cellular protection
against misfolded protein accumulation [45] and cell death [46]
under acute insults (i.e. acute cardiac ischemia-reperfusion injury).
However, during chronic degenerative diseases such as heart
failure, increased chaperones expression does not overcome the
deleterious effects generated by accumulation of misfolded
proteins.
Considering that maintenance of protein quality control is
crucial to protect long-lived cells, such as cardiomyocytes and
neurons, we evaluated whether mitochondrial dysfunction-medi-
ated oxidative stress could affect proteasomal activity and overall
protein quality control in cultured isolated cardiomyocytes. Either
Antimycin A or H2O2 resulted in proteasomal inactivation,
accumulation of oxidatively modified proteins and cell death in
cultured cardiomyocytes. These findings demonstrate that oxida-
tive stress-mediated chymotrypsin-like proteasomal inhibition (the
main proteasomal proteolytic site involved in protein degradation
and the most sensitive to 4-HNE modification) [10] decreases
cardiomyocyte viability and contributes, at least in part, to the
disruption of cardiac protein quality control in cardiomyocytes.
We have previously shown that improvement of proteasomal
activity using pharmacological tools protects neonatal cardiomy-
ocytes against H2O2-induced cell death [42].
Emerging studies have revealed that disruption of cardiac
mitochondrial metabolism and/or proteasomal insufficiency are
Figure 5. Oxidative stress contributes to proteasomal inactivation, accumulation of damaged proteins and cell death in cultured
neonatal cardiomyocytes. Proteasomal activity (A), oxidized protein levels and representative blots (B) and cell death (C) in cultured neonatal
cardiomyocytes. Concordance between proteasomal activity, oxidized protein levels and cell death in cultured neonatal cardiomyocytes (D). Cells
were stimulated with antimycin A (100 mM, Ant A, gray bars) or H2O2 (100 mM, gray bars) or Epoxomicin (1 mM, EPO, gray bars) for 2 hours.
Measurements were performed 24 hrs after treatments. Experiments were repeated at least 5 times. Protein expression was normalized by GAPDH.
Error bars indicate SEM. Proteasomal activity [F (3, 20) = 30.85, p,0.0001]; oxidized protein levels [F (2, 9) = 21.84, p = 0.0003] and cell death [F (3,
14) = 27.53, p,0.0001]. #, p,0.05 vs. non-treated cells (control). $, p,0.05 vs. antimycin A- and Epoxomicin-treated cells.
doi:10.1371/journal.pone.0052764.g005
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not only implicated but also play an important role in cardiac
pathogenesis. In fact, selective pharmacological and genetic
therapies capable to rescue either mitochondrial metabolism or
proteasomal activity improve cardiac function in different heart
disease animal models [39,42,47,48]. However, considering that
both mitochondrial metabolism and proteasomal function are
highly regulated by different cellular processes, we cannot exclude
the possibility that these changes are secondary to the compro-
mised cardiac function. Therefore, further studies investigating
both direct and indirect proteasomal regulation by oxidative stress
during heart failure progression are required. Also, the contribu-
tion of oxidative stress to other proteolytic systems such as
autophagic/lysosomal pathways, and its effect on cardiac protein
quality control in HF should be considered.
The possible mechanisms involved in 4-HNE-mediated protea-
somal inhibition have been previously described in different cell
lines and systems, including the heart. Analysis of two-dimension
gel electrophoresis from purified proteasomes followed by mass
spectrometry demonstrated that 4-HNE modification is not a
random process and that specific proteasomal subunits, mainly a-
subunits, are targeted by 4-HNE in the heart [9,10,49]. However,
since the proteasomal catalytic sites are located in the b subunits
(b1, b2 and b5), it has been suggested that an indirect mechanism,
probably mediated by protein-protein interactions between
regulatory and catalytic subunits, drives the inhibition of
proteasomal peptidase activity mediated by 4-HNE. Indeed,
further studies are required to better clarify this issue.
Another important finding of this study is the efficacy of exercise
training in restoring cardiac mitochondrial function, proteasomal
activity and protein quality control in heart failure animals.
Exercise capacity has been widely recognized an independent
predictor of mortality in patients with cardiovascular diseases [24].
Moreover, exercise training is considered an important adjuvant in
the treatment of heart failure since it increases both peak VO2 and
exercise tolerance, resulting in improved patient outcome and
quality of life [4,5,6]. However, the mechanisms underlying
exercise-induced beneficial effect on heart failure are not
completely understood.
Over the last decades, several studies have demonstrated the
contribution of exercise training to improve expression of
mitochondrial markers of biogenesis and metabolism in heart
failure. However, the contribution of exercise training to
mitochondrial physiology and its extension to cytosolic systems
related to cell survival during heart failure remains unclear. A
recent study has demonstrated that low-intensity interval exercise
training decreases calcium-induced mitochondrial permeability
transition in aortic-banded miniature swine [2], which may
positively affect cytosolic systems. In addition, exercise training
has been shown to improve cardiac redox balance in young and
old healthy animals [23,50]. We extended these findings by
showing that 8 weeks of aerobic exercise training restored
Figure 6. Exercise training improves protein quality control in myocardial infarction-induced heart failure. Oxidized protein levels (A),
soluble oligomers accumulation (B), HSP25 (C) ab-crystallin (D) protein levels in heart samples from 24 week-old control (sham, white bars), MI-HF
(gray bars) and MI-HF exercise trained (MI-HFtr, gray bars) rats. Representative blots of oxidized protein, soluble oligomers, HSP25, ab-crystallin and
GAPDH (E). All measurements were performed in the ventricular remote area. Protein expression was normalized by GAPDH. Error bars indicate SEM.
Oxidized protein levels [F (2, 19) = 5.25, p = 0.0312]; soluble oligomers accumulation [F (2, 15) = 3.97, p = 0.0412]; HSP25 [F (2, 19) = 4.21, p = 0.0306]
and ab-crystallin proteins levels [F (2, 17) = 1.49, p = 0.0252]. *, p,0.05 vs. control (sham) rats. {, p,0.05 vs. MI-HFtr rats.
doi:10.1371/journal.pone.0052764.g006
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oxidative phosphorylation efficiency along with a reduction in
H2O2 release and increased maximum calcium uptake in isolated
mitochondria from myocardial infarction-induced heart failure
rats. Interestingly, exercise training had a positive impact on
cytosolic protein quality control machinery by re-establishing the
proteasomal activity in failing hearts. These findings suggest that
reduced cardiac oxidative stress along with better protein quality
control are associated with the benefits promoted by exercise
training in heart failure rats. However, considering the complexity
of mitochondrial metabolism and protein quality control machin-
ery, further investigations need to be conducted in order to
establish a cause-and-effect relationship as well as clarify other
possible regulatory mechanisms regulated by exercise training in
heart failure.
In summary, we provide evidence that myocardial-infarction
induced heart failure rats display a prominent cardiac mitochon-
drial dysfunction, 4-HNE accumulation and cytosolic protein
quality control disruption. In addition, the ability of exercise
training to rescue mitochondrial function, decrease 4-HNE
accumulation and improve cardiac protein quality control in
heart failure highlights an important molecular mechanism
underlying the benefits of exercise training in failing hearts.
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